CN109260554A - 一种多功能健康养生雾化器及其养生药液和使用方法 - Google Patents
一种多功能健康养生雾化器及其养生药液和使用方法 Download PDFInfo
- Publication number
- CN109260554A CN109260554A CN201811362199.7A CN201811362199A CN109260554A CN 109260554 A CN109260554 A CN 109260554A CN 201811362199 A CN201811362199 A CN 201811362199A CN 109260554 A CN109260554 A CN 109260554A
- Authority
- CN
- China
- Prior art keywords
- medicine box
- health
- medical fluid
- storage medicine
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 155
- 230000036541 health Effects 0.000 title claims abstract description 106
- 239000007788 liquid Substances 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 21
- 238000003860 storage Methods 0.000 claims abstract description 99
- 238000000889 atomisation Methods 0.000 claims abstract description 30
- 239000003595 mist Substances 0.000 claims abstract description 25
- 229940079593 drug Drugs 0.000 claims abstract description 22
- 229920000742 Cotton Polymers 0.000 claims abstract description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 105
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 81
- 239000012530 fluid Substances 0.000 claims description 78
- 239000000284 extract Substances 0.000 claims description 47
- 235000013311 vegetables Nutrition 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000008213 purified water Substances 0.000 claims description 25
- 230000000147 hypnotic effect Effects 0.000 claims description 20
- 208000007848 Alcoholism Diseases 0.000 claims description 18
- 201000007930 alcohol dependence Diseases 0.000 claims description 18
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 17
- 210000004185 liver Anatomy 0.000 claims description 17
- 230000001256 tonic effect Effects 0.000 claims description 16
- 230000002936 tranquilizing effect Effects 0.000 claims description 16
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 14
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 14
- 229940041616 menthol Drugs 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 230000002929 anti-fatigue Effects 0.000 claims description 13
- 239000000341 volatile oil Substances 0.000 claims description 11
- 230000035622 drinking Effects 0.000 claims description 10
- 230000003796 beauty Effects 0.000 claims description 9
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 8
- 235000020733 paullinia cupana extract Nutrition 0.000 claims description 8
- 241000723346 Cinnamomum camphora Species 0.000 claims description 7
- 229930008380 camphor Natural products 0.000 claims description 7
- 229960000846 camphor Drugs 0.000 claims description 7
- 235000012907 honey Nutrition 0.000 claims description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 6
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 6
- 229940116229 borneol Drugs 0.000 claims description 6
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 6
- 230000007958 sleep Effects 0.000 claims description 6
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 5
- 244000119298 Emblica officinalis Species 0.000 claims description 5
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 4
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 claims description 4
- 241000255789 Bombyx mori Species 0.000 claims description 4
- 244000276331 Citrus maxima Species 0.000 claims description 4
- 235000001759 Citrus maxima Nutrition 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 241000598860 Garcinia hanburyi Species 0.000 claims description 4
- 241000146384 Glaux Species 0.000 claims description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 4
- 244000178870 Lavandula angustifolia Species 0.000 claims description 4
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 4
- 241000218394 Magnolia liliiflora Species 0.000 claims description 4
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 4
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 235000021028 berry Nutrition 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 229960001305 cysteine hydrochloride Drugs 0.000 claims description 4
- 229940117709 gamboge Drugs 0.000 claims description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 239000001102 lavandula vera Substances 0.000 claims description 4
- 235000018219 lavender Nutrition 0.000 claims description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 4
- 235000019136 lipoic acid Nutrition 0.000 claims description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 235000021283 resveratrol Nutrition 0.000 claims description 4
- 229940016667 resveratrol Drugs 0.000 claims description 4
- 229960002663 thioctic acid Drugs 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 240000002924 Platycladus orientalis Species 0.000 claims description 3
- 240000006365 Vitis vinifera Species 0.000 claims description 3
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 3
- 229960003720 enoxolone Drugs 0.000 claims description 3
- 230000013011 mating Effects 0.000 claims description 3
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 claims description 3
- 240000002045 Guettarda speciosa Species 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- 235000013772 propylene glycol Nutrition 0.000 description 20
- 238000003756 stirring Methods 0.000 description 15
- 210000001331 nose Anatomy 0.000 description 13
- 240000003444 Paullinia cupana Species 0.000 description 11
- 235000000556 Paullinia cupana Nutrition 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 9
- 239000012467 final product Substances 0.000 description 7
- 210000003128 head Anatomy 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 206010041349 Somnolence Diseases 0.000 description 5
- 206010039083 rhinitis Diseases 0.000 description 5
- 230000033764 rhythmic process Effects 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 208000019116 sleep disease Diseases 0.000 description 4
- 208000022925 sleep disturbance Diseases 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 229940101267 panthenol Drugs 0.000 description 3
- 235000020957 pantothenol Nutrition 0.000 description 3
- 239000011619 pantothenol Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000006200 vaporizer Substances 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 244000061520 Angelica archangelica Species 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 235000019500 Grapefruit seed oil Nutrition 0.000 description 2
- 244000202052 Poncirus trifoliata Species 0.000 description 2
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000586 desensitisation Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 230000036578 sleeping time Effects 0.000 description 2
- 230000002618 waking effect Effects 0.000 description 2
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000928504 Centipeda minima Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000593508 Garcinia Species 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000269435 Rana <genus> Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 229960004538 alprazolam Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
- A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
- A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Insects & Arthropods (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
Abstract
一种多功能健康养生雾化器及其养生药液和使用方法,多功能健康养生雾化器包括分别设置于主机外壳上的贮药盒、雾化发热装置和供电模块,贮药盒上存储有养生药液,供电模块连接雾化发热装置;贮药盒滑动式设置于主机外壳上;贮药盒上设置有导液棉,养生药液经导液棉引导至雾化发热装置上;主机外壳上滑动式设置有用于推动贮药盒的推出开关,雾化发热装置与供电模块之间设置有电源开关,推出开关控制电源开关打开或闭合;推出开关带动贮药盒推出主机外壳一定位置时,电源开关闭合,雾化发热装置得电作业,以将养生药液雾化成药雾。本发明具有结构简单合理、使用安全、操作简单、一机多用、效果显著、应用广泛、方便携带、成本低、性能可靠等特点。
Description
技术领域
本发明涉及一种雾化器,特别涉及一种多功能健康养生雾化器及其养生药液和使用方法。
背景技术
雾化吸入是一种非常先进、快捷的治疗方法,采用雾化吸入原理实现的雾化治疗简单易实行和容易被接受;由于雾化治疗属于局部用药,其副作用比较少,所以越来越多的被应用于临床上;对于哮喘、支气管炎、鼻炎、咽炎、感冒、祛痰、咳嗽、肺气肿等呼吸道问题都有很好的治疗效果。目前市场上常见的医用雾化器有:压缩式雾化器(气体压缩式空气压缩雾化器)、超声波雾化器和网式雾化器,这些医用雾化器体积都比较大,一般只能在医院或家里使用,使用、携带均不方便,且多作为治疗疾病用,不适宜作为随身携带用于健康养生。如中国专利文献号CN105030515B于2017年11月24日公开了一种多功能美容增效机及用于该机的药液及其使用方法,该多功能美容增效机也是用于雾化香薰养生保健,但其体积较大,不便于携带,只适合于医院、养生馆、家里等场所使用。
随着生活节奏加快,现代社会节奏紧张,生活节奏加快焦急成为新常态,越来越多的人面临着巨大的工作和生活压力,加上不合理的饮食习惯及不良的生活方式对人体健康造成了巨大影响,从而引发了各类睡眠障碍,心理压力与疲劳无疑会引起精神憔悴、亚健康成职场常态,中国社会科学院城市发展与环境研究所及社会科学文献出版社共同发布的城市蓝皮书称:数据表明中国亚健康人群已超过75%,尤其白领、蓝领人群居多;
亚健康的三大危害:
1)亚健康是大多数慢性非传染性疾病的疾病前状态,大多数恶性肿瘤、心脑血管疾病和糖尿病等均是从亚健康人群转入的;
2)亚健康状态明显影响工作效能和生活、学习质量;影响睡眠质量,加重身心疲劳;
3)心理亚健康极易导致精神心理疾患,甚至造成***和家庭伤害。
“亚健康”目前已经成为了严重危害人们身心健康的“隐形杀手”,那么亚健康该如何调理呢?对于生活节奏紧张的白领、蓝领们,到专业养生院做养生似乎是一种奢望。
大健康产业已经是全球第一大产业,中国政府已经明确大健康产业为国家战略,大健康产业不同于传统医疗产业发展模式,国家健康委提出今后医药要从单一救治模式转向“防—治—养”一体化防治模式。为配合国家战略政策,克服现有医用雾化器存在的上述不足,有必要设计一种能解决上述问题的雾化器。
发明内容
本发明的目的旨在提供一种结构简单合理、使用安全、操作简单、一机多用、效果显著、应用广泛、方便携带、成本低、性能可靠的多功能健康养生雾化器及其养生药液和使用方法,以克服现有技术中的不足之处。
按此目的设计的一种多功能健康养生雾化器,包括分别设置于主机外壳上的贮药盒、雾化发热装置和供电模块,雾化发热装置设置于贮药盒上、以雾化贮药盒内的养生药液,供电模块连接雾化发热装置、以为雾化发热装置供电;其特征在于:所述贮药盒滑动式设置于主机外壳上;所述贮药盒上设置有导液棉,养生药液经导液棉引导至雾化发热装置上;所述主机外壳上滑动式设置有用于推动贮药盒的推出开关,雾化发热装置与供电模块之间设置有电源开关,推出开关带动贮药盒推出主机外壳一定位置时,电源开关闭合,雾化发热装置得电作业;所述养生药液包括安神催眠药液、减肥药液、解酒护肝药液、抗炎通鼻药液、提神醒脑抗疲劳药液、美容药液和/或生发黑发药液,贮药盒可存储不同的养生药液。
所述贮药盒拆卸式设置于主机外壳上,且贮药盒模块化的配套一个以上,不同的贮药盒存储不同的养生药液;所述贮药盒上设有电连接雾化发热装置的触电点,主机外壳上设有电连接供电模块的触电座,贮药盒与主机外壳组装时,触电点始终与触电座电连接;所述贮药盒上还设置有吸雾嘴和注液口。
上述的安神催眠药液,其特征在于:按重量百分比包括柏子仁精油0.2~1%、酸枣仁精油0.2~1%、远志提取物0.2~2%、γ-氨基丁酸0.2~2%、L-色氨酸0.1~1%、薰衣草精油0.005~0.02%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
上述的减肥药液,其特征在于:按重量百分比包括藤黄果提取物0.2~2%、瓜拉纳提取物0.2~2%、决明子提取物0.2~2%、左旋肉碱0.2~2%、柚子精油0.1~1%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
上述的解酒护肝药液,其特征在于:按重量百分比包括葛花提取物0.2~2%、枳椇子提取物0.2~2%、余甘子提取物0.2~2%、蜂蜜0.2~2%、薄荷醇0.1~2%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
上述的抗炎通鼻药液,其特征在于:按重量百分比包括辛夷花提取物0.2~2%、鹅不食草提取物0.2~2%、甘草次酸0.1~1%、白黎芦醇0.1~1%、樟脑0.2~2%、薄荷醇0.1~2%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
上述的提神醒脑抗疲劳药液,其特征在于:按重量百分比包括瓜拉纳提取物0.2~2%、咖啡0.2~2%、樟脑0.2~2%、冰片0.1~1%、薄荷醇0.1~1%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
上述的美容药液,其特征在于:按重量百分比包括胶原蛋白0.5~2%、蚕丝多肽0.1~1%、维生素C 0.5~2%、硫辛酸0.1~1%、盐酸半胱氨酸0.2~2%、泛醇0.2~2%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
上述的生发黑发药液,其特征在于:按重量百分比包括何首乌提取物0.2~2%、当归提取物0.2~2%、三七提取物0.1~1%、苯丙氨酸0.5~1%、透骨提取物0.2~2%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
上述多功能健康养生雾化器的使用方法,其特征在于:
养生安神催眠:往贮药盒加入相应的安神催眠药液2毫升,睡前吸15~20口,吸后上床睡觉;
养生减肥:往贮药盒加入相应的减肥药液2毫升,每次吸15~20口,每天吸3~5次;
解酒护肝:往贮药盒加入相应的解酒护肝药液2毫升,喝酒期间边喝酒边吸,每次吸20~30口,吸5~8次,酒后再吸2次;
抗炎通鼻:往贮药盒加入相应的抗炎通鼻药液2毫升,每次吸15~20口,每天吸3~5次;
美容美发:往贮药盒加入相应的美容美发药液2毫升,每次吸15~20口,每天吸3~5次;
提神醒脑抗疲劳:往贮药盒加入相应的提神醒脑药液2毫升,开车打瞌睡或者工作疲劳时每次吸15~20口,每天吸5~10次;
生发黑发药液:往贮药盒加入相应的生发黑发药液2毫升,每次吸15~20口,每天吸3~5次。
本发明的多功能健康养生雾化器体积小巧、经济成本低,方便携带、使用方便,其具有巨大的社会效益,实现在不同场所自己一人就可随时随地进行健康养生的效果;且由于本多功能健康养生雾化器所应用的养生药液能快速见效,所以非常适合工作生活节奏紧张的人使用;本多功能健康养生雾化器可成为当代人健康养生的不二选择。具体是,
本发明的多功能健康养生雾化器以电子加热雾化方式,再配合适用于本多功能健康养生雾化器的养生药液,达到健康养生的目的;本多功能健康养生雾化器可通过贮药盒存储不同的养生药液或者通过配套存储不同养生药液的贮药盒,能满足不同用户的需要,实现一机多用的效果;
应用于本多功能健康养生雾化器的养生药液通过雾化发热装置雾化成药雾,再用口将药雾吸入肺部经肺泡交换吸收,以直接发挥药效,达到安神催眠、减肥美容美发、解酒护肝、抗炎脱敏、提神醒脑抗疲劳、生发黑发等功效。各功效的具体操作如下:1、往贮药盒加入安神催眠药液,雾化吸入,可起到安神催眠功效,用于治疗睡眠障碍或失眠;2、往贮药盒加入减肥药液,雾化吸入,可起到减肥功效,用于肥胖症;3、往贮药盒加入解酒护肝药液,雾化吸入,可起到解酒护肝功效;4、往贮药盒加入抗炎通鼻药液,雾化吸入,用于治疗过敏性鼻炎;5、往贮药盒加入提神醒脑抗疲劳药液,雾化吸入,用于开车防打瞌睡或者工作疲劳;6、往贮药盒加入美容药液,雾化吸入,可起到美容嫩肤防衰老功效;7、往贮药盒加入生发黑发药液,雾化吸入,用于防脱、生发、养发黑发。
附图说明
图1为本发明一实施例组装状态的正面结构示意图。
图2为本发明一实施例组装状态的侧面结构示意图。
图3为本发明一实施例使用状态的正面结构示意图。
图4为本发明一实施例使用状态的侧面结构示意图。
图5为本发明一实施例锁止块对贮药盒解锁的侧面结构示意图。
图6为本发明一实施例贮药盒与主机外壳分离的侧面结构示意图。
图7为本发明一实施例贮药盒与主机外壳分离的正面结构示意图。
具体实施方式
下面结合附图及实施例对本发明作进一步描述。
参见图1和图7,本多功能健康养生雾化器,包括分别设置于主机外壳1上的贮药盒3、雾化发热装置5和供电模块7,贮药盒3内腔根据使用需要可存储不同的养生药液,供电模块7连接雾化发热装置5、以为雾化发热装置5供电;贮药盒3滑动式设置于主机外壳1顶部的储存室1.1;贮药盒3内腔设置有导液棉4,养生药液经导液棉4引导至雾化发热装置5上,以便雾化发热装置5对养生药液进行雾化;主机外壳1外侧滑动式设置有用于推动贮药盒3的推出开关9,雾化发热装置5与供电模块7之间设置有电源开关6,推出开关9控制电源开关6打开或闭合;推出开关9带动贮药盒3推出主机外壳1一定位置时,电源开关6闭合,雾化发热装置5得电作业,以将养生药液雾化成药雾,再由用户吸入肺部,以便药雾经肺泡交换并能快速吸收进入血液循环,达到养生保健功效;推出开关9带动贮药盒3复位后,电源开关6打开,雾化发热装置5失电停机。
进一步说,贮药盒3拆卸式设置于主机外壳1顶部的储存室1.1,贮药盒3外底部设置有电连接雾化发热装置5的触电点13;主机外壳1顶部的储存室1.1内滑动式设置有推出板14,推出板14顶部设置有电连接供电模块7的触电座15,推出开关9传动连接推出板14;贮药盒3与主机外壳1组装时,贮药盒3支承于推出板14上,且触电点13与触电座15电连接,使雾化发热装置5与电源开关6电连接;使用时,推出开关9通过推出板14带动贮药盒3推出主机外壳1,贮药盒3始终支承于推出板14上,确保触电点13与触电座15始终电连接,进而保证雾化发热装置5与电源开关6始终电连接。
进一步说,贮药盒3内腔设有储药室3.1和雾化室3.2,养生药液储存于储药室3.1中,导液棉4和雾化发热装置5分别设置于雾化室3.2中,导液棉4至少部分伸入储药室3.1中与养生药液接触,导液棉4能有效将储药室3.1中的养生药液引导至雾化发热装置5进行雾化。贮药盒3、导液棉4和雾化发热装置5共同组成一整体,实现贮药盒3的模块化设置,因此贮药盒3可配备多个并可根据不同的养生需要分别加入不同养生药液,以防止同一贮药盒3分别加入不同的养生药液导致药液交叉污染而影响使用效果。
进一步说,推出开关9上设置有可弹性活动的锁止块17,锁止块17顶端内侧设有扣位17.1,扣位17.1与贮药盒3侧部的扣孔3.3相互弹性扣接,实现贮药盒3与推出开关9和推出板14的连接;当手动或通过工具作用锁止块17,使扣位17.1脱离扣孔3.3时,贮药盒3可与主机外壳1分离拆卸。具体是,锁止块17中部弹性复位的转动连接在推出开关9上,手动或通过工具按压锁止块17底部时,扣位17.1外翻,实现扣位17.1与扣孔3.3分离;扣位17.1上设有导向面,贮药盒3安装时通过导向面作用扣位17.1外翻,直至贮药盒3越过扣位17.1,且扣位17.1与扣孔3.3扣接,即可完成贮药盒3的安装。
进一步说,主机外壳1内腔设置有复位拉簧16,复位拉簧16一端相对连接推出板14、另一端相对连接主机外壳1,复位拉簧16作用推出板14和推出开关9相对主机外壳1弹性复位滑动;使贮药盒3在不使用时可自动退入主机外壳1中,且使电源开关6打开、雾化发热装置5断电、避免浪费电能。
进一步说,贮药盒3顶部设有吸雾嘴2,吸雾嘴2内设有吸管12,吸管12的进口端伸入雾化室3.2且位于雾化发热装置5上方,经雾化发热装置5雾化的药雾可经过吸管12往外排,吸管12的出口端外露于吸雾嘴2上,方便用户实施吸雾。
进一步说,贮药盒3顶部设有连通储药室3.1的注液口11,注液口11始终外露于主机外壳1,方便用户随时补充养生药液。
进一步说,主机外壳1侧部设置有充电接头10,该充电接头10电连接供电模块7,通过充电接头10可为供电模块7充电;供电模块7为可充电的锂电池。
进一步说,主机外壳1表面设置有指示灯8,指示灯8电连接供电模块7,指示灯8可提示用户多功能健康养生雾化器正处于什么工作状态。
(一)静心安神催眠
安神催眠药液,按重量百分比包括柏子仁精油1%、酸枣仁精油1%、远志提取物2%、γ-氨基丁酸1%、L-色氨酸0.5%、薰衣草精油0.01%、纯化水15%、丙二醇25%、余量为蔬菜甘油。
安神催眠药液的配制方法如下:首先取γ-氨基丁酸、L-色氨酸和远志提取物加纯化水加热溶解;然后加入丙二醇和蔬菜甘油搅拌溶解;再缓缓加入薰衣草精油搅拌溶解;最后添加蔬菜甘油至全量,搅拌均匀,过滤即得。
使用方法:往贮药盒3加入安神催眠药液2毫升,将贮药盒3放入多功能健康养生雾化器中,睡前吸15~20口,吸后上床睡觉;可起到安神催眠功效,用于治疗睡眠障碍、失眠。
原理:安神中药和助眠氨基酸药雾通过肺泡迅速进入血液大脑皮层中,补充、调节脑松果体分泌睡眠因子,具有明显的镇静和催眠作用,促使患者快速进入自然睡眠。
(二)吸香享瘦减肥
减肥药液,按重量百分比包括藤黄果提取物1%、瓜拉纳提取物2%、决明子提取物0.5%、左旋肉碱1%、柚子精油1%、纯化水20%、丙二醇30%、余量为蔬菜甘油。
减肥药液的配制方法如下:首先取左旋肉碱、藤黄果提取物、瓜拉纳提取物和决明子提取物加纯化水加热溶解;然后加入丙二醇和蔬菜甘油搅拌溶解;再缓缓加入柚子精油搅拌溶解;最后添加蔬菜甘油至全量,搅拌均匀,过滤即得。
使用方法:往贮药盒3加入减肥药液2毫升,将贮药盒3放入多功能健康养生雾化器中,每次吸15~20口,每天吸3~5次;可起到减肥降脂功效,用于肥胖、大肚腩。
原理:左旋肉碱、藤黄果、决明子是常用有效的减肥降脂药物。“瓜拉纳”能有效促进新陈代谢,改善人体内环境;一方面燃烧体内多余的顽固性脂肪,另一方面加快细胞的代谢活动、促进脂肪的消耗;《人类营养饮食杂志》的文章中报道了服用含有“瓜拉纳”药物超过45天,能使超重患者的体重下降;与服用45天安慰剂(不含任何实际效果的药物)组相比,安慰剂组体重减轻了1磅,瓜拉纳组体重减轻11.22磅;一些减轻体重的专利配方中都含有瓜拉纳;在不久将来,以瓜拉纳为主要成分的减肥药,很快就会出现在我们的生活中,从而在很大程度上改变肥胖人士的生活和命运。“瓜拉纳燃烧脂肪”+“柚子油闻香减肥”的相乘作用达成减肥大业;这种“多维立体”、“吸香减肥法”的原理是:利用可分解“中性脂肪”的“瓜拉纳”和“柚子油”可促进脂肪燃烧的SLM香氛;香氛和瓜拉纳两种元素汇集,能产生神奇的相乘作用,吸入香气,刺激肾上腺素分泌,便能在体内完成整个燃烧脂肪的过程。
(三)解酒护肝
解酒护肝药液,按重量百分比包括葛花提取物1.5%、枳椇子提取物2%、余甘子提取物1%、蜂蜜1.5%、薄荷醇0.5%、纯化水15%、丙二醇25%、余量为蔬菜甘油。
解酒护肝药液的配制方法如下:首先取葛花提取物、枳椇子提取物和余甘子提取物加纯化水加热溶解;然后加入蜂蜜、丙二醇和蔬菜甘油搅拌溶解;再加入薄荷醇搅拌溶解;最后添加蔬菜甘油至全量,搅拌均匀,过滤即得。
使用方法:往贮药盒3加入解酒护肝药液2毫升,将贮药盒3放入多功能健康养生雾化器中,喝酒期间边喝酒边吸,每次吸20~30口,吸5~8次,酒后再吸2次;可起到解酒护肝功效。
原理:本发明选用有显著解酒功效的枳椇子、葛花、余柑子等草本植物及蜂蜜配方,一吸见效。其中,枳椇子:现代药理学证实,枳椇子有显著利尿作用,是一种解酒良药;枳椇子能显著降低乙醇在血液中的浓度,促进乙醇的清除,消除酒后体内产生的过量自由基,阻碍过氧化脂质的形成,从而减轻乙醇对肝组织的损伤,避免酒精中毒导致各种代谢异常而诱发各种疾病。葛花:具有解酒醒脾之功效,主要用于饮酒过度伤及胃气之头痛、头昏、烦渴、胸膈饱胀、呕吐酸水等。蜂蜜:主要是利用蜂蜜中的特殊果糖,可有效分解和吸收酒精,从而起到快速醒酒的作用,消除酒后头痛、头晕现象。
(四)抗炎通鼻
抗炎通鼻药液,按重量百分比包括辛夷花提取物2%、鹅不食草提取物1.5%、甘草次酸0.5%、白黎芦醇0.5%、樟脑0.5%、薄荷醇1%、纯化水15%、丙二醇30%、余量为蔬菜甘油。
抗炎通鼻药液的配制方法如下:首先取辛夷花提取物、鹅不食草提取物和余甘子提取物加纯化水加热溶解;然后加入丙二醇和蔬菜甘油搅拌溶解;再加入甘草次酸、白黎芦醇和薄荷醇搅拌溶解;最后添加蔬菜甘油至全量,搅拌均匀,过滤即得。
使用方法:往贮药盒3加入抗炎通鼻药液2毫升,将贮药盒3放入多功能健康养生雾化器中,每次吸15~20口,每天吸3~5次。
原理:以《药性赋》中鼻炎要药:辛夷花、鹅不食草为主药,配以具抗炎作用的甘草次酸、白黎芦醇以及清凉通鼻的薄荷醇对鼻腔有较好的消炎、清洗、修复、脱敏作用,对***反应疾病产生有益的影响,对过敏性鼻炎疗效尤为显著。
(五)美容抗衰老
美容药液,按重量百分比包括胶原蛋白1%、蚕丝多肽1%、维生素C 1.5%、硫辛酸0.3%、盐酸半胱氨酸0.5%、泛醇1%、纯化水20%、丙二醇10%、余量为蔬菜甘油。
美容药液的配制方法如下:首先取胶原蛋白、蚕丝多肽、维生素C、盐酸半胱氨酸和泛醇加纯化水加热溶解;然后加入丙二醇和蔬菜甘油搅拌均匀;再加入硫辛酸搅拌溶解;最后添加蔬菜甘油至全量,搅拌均匀,过滤即得。
使用方法:往贮药盒3加入美容美发药液2毫升,将贮药盒3放入多功能健康养生雾化器中,每次吸15~20口,每天吸3~5次;用于祛斑美白、嫩肤、消除皱纹、抗衰老美容。
(六)提神醒脑抗疲劳
提神醒脑抗疲劳药液,按重量百分比包括瓜拉纳提取物2%、咖啡1.2%、樟脑1%、冰片0.5%、薄荷醇0.5%、纯化水15%、丙二醇30%、余量为蔬菜甘油。
提神醒脑抗疲劳药液的配制方法如下:首先取瓜拉纳提取物和咖啡加纯化水加热溶解;然后加入丙二醇和蔬菜甘油搅拌均匀;再加入樟脑、冰片和薄荷醇搅拌溶解;最后添加蔬菜甘油至全量,搅拌均匀,过滤即得。
使用方法:往贮药盒3加入提神醒脑药液2毫升,将贮药盒3放入多功能健康养生雾化器中,开车打瞌睡或者工作疲劳时每次吸15~20口,每天吸5~10次。
原理:本品以亚马逊的热带丛林的野生“瓜拉纳”具有类似咖啡因兴奋大脑皮层作用,再加之咖啡、天然樟脑、龙脑(冰片)和薄荷醇“醒脑提神”,发挥1+2>3的倍增功效;吸一吸提神醒脑、滋阴壮阳、恢复体力、补充能量、强身健体,使人精神爽利、体力充沛。来自亚马逊丛林的长寿秘密——瓜拉纳为主药,在最不利于人类生存的亚马逊的热带丛林,“瓜拉纳”野生地区却有很多百岁老人;数百年来当地的印度安人平均寿命高达八十多岁,比巴西及世界其它文明城市还高出很多;更奇特的是他们七、八十岁的老人,不仅外表有如四、五十岁的人,而且活力四射,精力充沛;其原因便是当地的印第安人每日均食用“瓜拉纳”,“瓜拉纳”是赐予他们青春、美丽和健康长寿的秘密。
(七)生发黑发
生发黑发药液,按重量百分比包括何首乌提取物2%、当归提取物1%、三七提取物1%、苯丙氨酸1%、透骨提取物1.5%、纯化水20%、丙二醇20%、余量为蔬菜甘油。
生发黑发药液的配制方法如下:首先取苯丙氨酸、何首乌提取物、当归提取物、三七提取物和透骨提取物加纯化水加热溶解;然后加入丙二醇和蔬菜甘油搅拌均匀;最后添加蔬菜甘油至全量,搅拌均匀,过滤即得。
使用方法:往贮药盒3加入生发黑发药液2毫升,将贮药盒3放入多功能健康养生雾化器中,每次吸15~20口,每天吸3~5次;具有防脱、生发、养发黑发的功效。
典型实验病例
典型病例1:暨XX,男,48岁,因工作压力大,患睡眠障碍10年多,每晚入睡困难、易醒、醒后难睡,每晚睡眠时间少于3小时,需长期服用安定、阿普***等***,造成神经衰弱、忧郁症。使用本多功能养生雾化器的静心安神催眠药液吸入3次后,可以在20分钟内入睡,睡眠时间可达7小时,再连续使用21次后,可停止服用***,避免了长期服用***的危害,恢复了自然睡眠。
典型实验病例2:黄XX,男,33岁,身高172厘米,体重95公斤,腰围39英寸,曾试用多种减肥方法效果均不明显,脸部粗糙暗黄、多处色斑、黑眼圈,鱼尾纹,曾用许多化妆品效果不理想;使用本多功能养生雾化器的吸香享瘦减肥养生药液吸入,并配合使用配套的闻香享瘦按摩膏按摩,40天后,减重8公斤,腰围减至35英寸,虽然效果较慢,但患者感觉使用方便,安全、无任何副作用,其认为是最轻松、安全有效的减肥方法。
典型实验病例3:张XX,男,42岁,需经常应酬喝酒,喝醉成常态,造成身体状况越来越差,自从使用本多功能养生雾化器的解酒护肝药液吸入后,近半年以来没有喝醉过,酒后再没有头痛、头晕与宿醉现象;不过量喝,酒后1小时用酒精测试仪吹气检测酒精浓度小于20mg/100ml,低于酒驾标准。
典型实验病例4:赵XX,男,29岁,经常跑长途货运,好几次因犯困打瞌睡险些出事故,自从车上备用了本多功能养生雾化器的提神醒脑抗疲劳药液后,开车犯困时就吸10多口(次),就能醒脑提神不再犯困,精神爽利,认为是开车防事故的护身宝。
典型实验病例5:黎XX,女,32岁,患慢性过敏性鼻炎10年,鼻流浊涕、量多、鼻塞、嗅觉减退以及头痛等,在冷、热环境交替中更易发作,曾使用多种抗过敏药物治疗,效果不佳,使用本多功能养生雾化器的抗炎通鼻药液吸入5次后,使鼻塞减轻,再连续喷鼻14天,所有鼻炎症状消失,痊愈。
典型实验病例6:刘XX,男,35岁,经常通宵熬夜,疲劳不堪,工作经常出差错,使用了本多功能养生雾化器的提神醒脑抗疲劳药液后,疲劳犯困时就吸10多口(次),就能醒脑提神不再犯困,精神爽利,工作效率提高,受到公司奖励。
上述为本发明的优选方案,显示和描述了本发明的基本原理、主要特征和本发明的优点。本领域的技术人员应该了解本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等同物界定。
Claims (10)
1.一种多功能健康养生雾化器,包括分别设置于主机外壳(1)上的贮药盒(3)、雾化发热装置(5)和供电模块(7),贮药盒(3)上存储有养生药液,供电模块(7)连接雾化发热装置(5);其特征在于:所述贮药盒(3)滑动式设置于主机外壳(1)上;所述贮药盒(3)上设置有导液棉(4),养生药液经导液棉(4)引导至雾化发热装置(5)上;所述主机外壳(1)上滑动式设置有用于推动贮药盒(3)的推出开关(9),雾化发热装置(5)与供电模块(7)之间设置有电源开关(6),推出开关(9)控制电源开关(6)打开或闭合;推出开关(9)带动贮药盒(3)推出主机外壳(1)一定位置时,电源开关(6)闭合,雾化发热装置(5)得电作业,以将养生药液雾化成药雾;所述养生药液包括安神催眠药液、减肥药液、解酒护肝药液、抗炎通鼻药液、提神醒脑抗疲劳药液、美容药液和/或生发黑发药液,贮药盒(3)可存储不同的养生药液。
2.根据权利要求1所述多功能健康养生雾化器,其特征在于:所述贮药盒(3)拆卸式设置于主机外壳(1)上,且贮药盒(3)模块化的配套一个以上,不同的贮药盒(3)存储不同的养生药液;所述贮药盒(3)上设有电连接雾化发热装置(5)的触电点(13),主机外壳(1)上设有电连接供电模块(7)的触电座(15),贮药盒(3)与主机外壳(1)组装时,触电点(13)始终与触电座(15)电连接;所述贮药盒(3)上还设置有吸雾嘴(2)和注液口(11)。
3.根据权利要求1所述的安神催眠药液,其特征在于:按重量百分比包括柏子仁精油0.2~1%、酸枣仁精油0.2~1%、远志提取物0.2~2%、γ-氨基丁酸0.2~2%、L-色氨酸0.1~1%、薰衣草精油0.005~0.02%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
4.根据权利要求1所述的减肥药液,其特征在于:按重量百分比包括藤黄果提取物0.2~2%、瓜拉纳提取物0.2~2%、决明子提取物0.2~2%、左旋肉碱0.2~2%、柚子精油0.1~1%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
5.根据权利要求1所述的解酒护肝药液,其特征在于:按重量百分比包括葛花提取物0.2~2%、枳椇子提取物0.2~2%、余甘子提取物0.2~2%、蜂蜜0.2~2%、薄荷醇0.1~2%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
6.根据权利要求1所述的抗炎通鼻药液,其特征在于:按重量百分比包括辛夷花提取物0.2~2%、鹅不食草提取物0.2~2%、甘草次酸0.1~1%、白黎芦醇0.1~1%、樟脑0.2~2%、薄荷醇0.1~2%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
7.根据权利要求1所述的提神醒脑抗疲劳药液,其特征在于:按重量百分比包括瓜拉纳提取物0.2~2%、咖啡0.2~2%、樟脑0.2~2%、冰片0.1~1%、薄荷醇0.1~1%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
8.根据权利要求1所述的美容药液,其特征在于:按重量百分比包括胶原蛋白0.5~2%、蚕丝多肽0.1~1%、维生素C 0.5~2%、硫辛酸0.1~1%、盐酸半胱氨酸0.2~2%、泛醇0.2~2%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
9.根据权利要求1所述的生发黑发药液,其特征在于:按重量百分比包括何首乌提取物0.2~2%、当归提取物0.2~2%、三七提取物0.1~1%、苯丙氨酸0.5~1%、透骨提取物0.2~2%、纯化水5~20%、丙二醇5~40%、余量为蔬菜甘油。
10.如权利要求1所述多功能健康养生雾化器的使用方法,其特征在于:
养生安神催眠:往贮药盒(3)加入相应的安神催眠药液2毫升,睡前吸15~20口,吸后上床睡觉;
养生减肥:往贮药盒(3)加入相应的减肥药液2毫升,每次吸15~20口,每天吸3~5次;
解酒护肝:往贮药盒(3)加入相应的解酒护肝药液2毫升,喝酒期间边喝酒边吸,每次吸20~30口,吸5~8次,酒后再吸2次;
抗炎通鼻:往贮药盒(3)加入相应的抗炎通鼻药液2毫升,每次吸15~20口,每天吸3~5次;
美容美发:往贮药盒(3)加入相应的美容美发药液2毫升,每次吸15~20口,每天吸3~5次;
提神醒脑抗疲劳:往贮药盒(3)加入相应的提神醒脑药液2毫升,开车打瞌睡或者工作疲劳时每次吸15~20口,每天吸5~10次;
生发黑发药液:往贮药盒(3)加入相应的生发黑发药液2毫升,每次吸15~20口,每天吸3~5次。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811362199.7A CN109260554A (zh) | 2018-11-15 | 2018-11-15 | 一种多功能健康养生雾化器及其养生药液和使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811362199.7A CN109260554A (zh) | 2018-11-15 | 2018-11-15 | 一种多功能健康养生雾化器及其养生药液和使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109260554A true CN109260554A (zh) | 2019-01-25 |
Family
ID=65190280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811362199.7A Pending CN109260554A (zh) | 2018-11-15 | 2018-11-15 | 一种多功能健康养生雾化器及其养生药液和使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109260554A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111265541A (zh) * | 2020-03-22 | 2020-06-12 | 北京泰克美高新技术有限公司 | 一种用于改善失眠和缓解压力的液体制剂保健品 |
CN112370441A (zh) * | 2020-11-24 | 2021-02-19 | 沈阳药科大学 | 白藜芦醇-天然产物组合物及其双磷脂复合物 |
CN113797421A (zh) * | 2021-09-19 | 2021-12-17 | 武汉左点科技有限公司 | 一种失眠治疗控制方法及装置 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN200966824Y (zh) * | 2006-11-10 | 2007-10-31 | 韩力 | 吸入雾化装置 |
CN201067728Y (zh) * | 2007-07-17 | 2008-06-04 | 朱晓春 | 一种口吸式家用雾化器 |
CN102326869A (zh) * | 2011-05-12 | 2012-01-25 | 陈志平 | 电子雾化吸入器的雾化嘴 |
CN102727969A (zh) * | 2010-11-01 | 2012-10-17 | 卓尔悦(常州)电子科技有限公司 | 用于雾化器的控制电路及方法 |
CN104645204A (zh) * | 2015-03-03 | 2015-05-27 | 华健 | 一种具有解毒醒酒功能的电子雾化液及其制备方法 |
CN105030515A (zh) * | 2015-07-30 | 2015-11-11 | 刘贤英 | 多功能美容增效机及用于该机的药液及其使用方法 |
CN205005914U (zh) * | 2015-08-17 | 2016-02-03 | 深圳老友金科技有限公司 | 一种烟量可调的电子烟 |
CN107734983A (zh) * | 2015-07-07 | 2018-02-23 | 韩国烟草人参公社 | 电子烟 |
CN208064485U (zh) * | 2018-03-16 | 2018-11-09 | 卓尔悦欧洲控股有限公司 | 电子烟 |
-
2018
- 2018-11-15 CN CN201811362199.7A patent/CN109260554A/zh active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN200966824Y (zh) * | 2006-11-10 | 2007-10-31 | 韩力 | 吸入雾化装置 |
CN201067728Y (zh) * | 2007-07-17 | 2008-06-04 | 朱晓春 | 一种口吸式家用雾化器 |
CN102727969A (zh) * | 2010-11-01 | 2012-10-17 | 卓尔悦(常州)电子科技有限公司 | 用于雾化器的控制电路及方法 |
CN102326869A (zh) * | 2011-05-12 | 2012-01-25 | 陈志平 | 电子雾化吸入器的雾化嘴 |
CN104645204A (zh) * | 2015-03-03 | 2015-05-27 | 华健 | 一种具有解毒醒酒功能的电子雾化液及其制备方法 |
CN107734983A (zh) * | 2015-07-07 | 2018-02-23 | 韩国烟草人参公社 | 电子烟 |
CN105030515A (zh) * | 2015-07-30 | 2015-11-11 | 刘贤英 | 多功能美容增效机及用于该机的药液及其使用方法 |
CN205005914U (zh) * | 2015-08-17 | 2016-02-03 | 深圳老友金科技有限公司 | 一种烟量可调的电子烟 |
CN208064485U (zh) * | 2018-03-16 | 2018-11-09 | 卓尔悦欧洲控股有限公司 | 电子烟 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111265541A (zh) * | 2020-03-22 | 2020-06-12 | 北京泰克美高新技术有限公司 | 一种用于改善失眠和缓解压力的液体制剂保健品 |
CN112370441A (zh) * | 2020-11-24 | 2021-02-19 | 沈阳药科大学 | 白藜芦醇-天然产物组合物及其双磷脂复合物 |
CN113797421A (zh) * | 2021-09-19 | 2021-12-17 | 武汉左点科技有限公司 | 一种失眠治疗控制方法及装置 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100350925C (zh) | 一种鼻烟气雾剂 | |
CN102326642B (zh) | 美容养颜茶 | |
CN1981585B (zh) | 花卉普洱茶 | |
CN105030515B (zh) | 多功能美容增效机 | |
CN107233412A (zh) | 一种促进睡眠的复方精油组合物及其制备方法和用途 | |
CN109260554A (zh) | 一种多功能健康养生雾化器及其养生药液和使用方法 | |
CN101919982A (zh) | 一种解酒保肝的药物组合物及其功能口香糖 | |
CN102864063B (zh) | 花椒保健酒及其制备方法 | |
CN103393591A (zh) | 香体酵素沐浴露 | |
CN105902854A (zh) | 一种具有安神助眠功效的复方精油 | |
CN104433577A (zh) | 治疗失眠的药枕 | |
CN105167489A (zh) | 一种助眠复合药芯配方 | |
CN103719491B (zh) | 一种黄精健脾润肺保健茶及其制备方法 | |
CN105614719A (zh) | 一种美白祛斑的阿胶糕及其制备方法 | |
CN106641846B (zh) | 一种怡神led阅读灯 | |
CN105495373A (zh) | 一种抗衰老、美容养颜的缬草葡萄籽阿胶糕及其制备方法 | |
CN102028374A (zh) | 一种治疗失眠的药枕 | |
CN101972091A (zh) | 生物钟安神催眠药枕 | |
CN104524464A (zh) | 一种治疗多动症的中药制剂及其制备方法 | |
CN104719537B (zh) | 一种花茶组合物及其制备方法 | |
CN101822629B (zh) | 一种男士专用纯天然植物浓发精华液及其制备方法 | |
CN101130029B (zh) | 一种内服治疗情感性精神病的药物 | |
CN101856401B (zh) | 治疗失眠的外用中药组合物 | |
CN2361257Y (zh) | 经络火罐 | |
CN105533702A (zh) | 一种孕妇用的美白祛斑阿胶糕及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190125 |